Both agents synergistically reduced Vascular Endothelial Growth Factor (TFRC) expression and the concomitant degradation of Ferritin light chain (FTL) and ferritin heavy chain (FTH), thus promoting HCC cells toward ferroptosis [137]. Here, FTH1 is linked to hepatocellular carcinoma.